Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Tilray Brands's share price for the quarter that ended in Feb. 2026 was €6.74. Tilray Brands's Shares Outstanding (EOP) for the quarter that ended in Feb. 2026 was 116.2 Mil. Therefore, Tilray Brands's market cap for the quarter that ended in Feb. 2026 was €783.4 Mil.
Tilray Brands's quarterly market cap
declined
from Aug. 2025 (€1,334.1 Mil) to Nov. 2025 (€836.6 Mil) and
declined
from Nov. 2025 (€836.6 Mil) to Feb. 2026 (€783.4 Mil).
Tilray Brands's annual market cap
increased
from May. 2023 (€1,038.2 Mil) to May. 2024 (€1,384.7 Mil) but then
declined
from May. 2024 (€1,384.7 Mil) to May. 2025 (€415.0 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Tilray Brands's Enterprise Value for Today is €533.2 Mil.
Tilray Brands (WBO:TLR2) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Tilray Brands Market Cap Related Terms
Tilray Brands Market Cap Historical Data
* Premium members only.
The historical data trend for Tilray Brands's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:TLR2 vs IRWD, BIOA, ESPR: Market Cap Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tilray Brands Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's Market Cap distribution charts can be found below:
* The bar in red indicates where Tilray Brands's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Tilray Brands's Market Cap for the fiscal year that ended in May. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tilray Brands (WBO:TLR2) has a Market Cap of €475.0 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Tilray Brands and its competitors. According to the industry distribution chart, Tilray Brands ranks #365 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 35.7%.
Is Tilray Brands' Market Cap too high?
Tilray Brands' current Market Cap is €475.0 Mil. Based on the distribution chart, Tilray Brands ranks #365 out of 1023 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Tilray Brands has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tilray Brands' Market Cap compare to IRWD and BIOA?
According to the Drug Manufacturers industry distribution chart, Tilray Brands ranks #365 out of 1023 companies for Market Cap. This puts Tilray Brands in the upper half of its industry. The industry median Market Cap is 205.37. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 205.37, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Tilray Brands and its competitors. For the Drug Manufacturers industry, the median Market Cap is 205.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tilray Brands's current Market Cap is €475.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tilray Brands stock overvalued right now?
Based on GuruFocus' analysis, Tilray Brands (WBO:TLR2) is currently considered Possible Value Trap. The stock's GF Value™ is €10.82, compared to a current price of €3.92 — trading 63.8% below its estimated fair value. The current Market Cap is €475.0 Mil. Tilray Brands' overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Tilray Brands (WBO:TLR2), the current Market Cap is €475.0 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tilray Brands (WBO:TLR2) Overvalued in 2026?
Based on GuruFocus' analysis, Tilray Brands stock appears to be undervalued.
The current stock price of €3.92 is trading 63.8% below its estimated GF Value™ of €10.82.
GuruFocus considers Tilray Brands to be Possible Value Trap.
Key valuation signals for WBO:TLR2:
Market Cap: €475.0 Mil
GF Value™: €10.82 vs. price of €3.92 (63.8% below fair value)
No single metric tells the full story. See the WBO:TLR2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
55GF Score
Get the complete analysis for WBO:TLR2
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:TLR2 has been successfully added to your 
